BDTX BLACK DIAMOND THERAPEUTICS INC Investments/Divestments 8-K Filing 2023 - Underwriting Agreement Black Diamond Therapeutics, Inc. entered into an underwriting agreement with Piper Sandler & Co. for an underwritten public offering of up to 15,000,000 shares of common stock at a price of $5.00 per share, with an option for the underwriters to purchase additional shares.Get access to all SEC 8-K filings of the BLACK DIAMOND THERAPEUTICS INC